Cingulate Inc. Proxy Statement Supplement Filed
Ticker: CINGW · Form: DEFA14A · Filed: Jul 12, 2024 · CIK: 1862150
| Field | Detail |
|---|---|
| Company | Cingulate Inc. (CINGW) |
| Form Type | DEFA14A |
| Filed Date | Jul 12, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $10,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, stockholder-meeting, supplemental-filing
TL;DR
Cingulate Inc. dropped a proxy update for their July 30th meeting. Check it out.
AI Summary
Cingulate Inc. filed a Definitive Additional Materials proxy statement on July 12, 2024, supplementing its proxy materials for a special meeting of stockholders scheduled for July 30, 2024. The company is based in Kansas City, KS, and operates in the pharmaceutical preparations sector. This filing does not appear to involve a fee.
Why It Matters
This filing provides updated information to Cingulate Inc. stockholders regarding an upcoming special meeting, ensuring they have the latest details for their voting decisions.
Risk Assessment
Risk Level: low — This is a routine proxy statement supplement, not indicating any immediate financial or operational risks.
Key Players & Entities
- Cingulate Inc. (company) — Registrant
- 20240712 (date) — Filing Date
- July 30, 2024 (date) — Special Meeting Date
- Kansas City, KS (location) — Company Address
FAQ
What is the purpose of this DEFA14A filing?
This filing is a Definitive Additional Materials proxy statement supplement for Cingulate Inc., providing additional information to stockholders for an upcoming special meeting.
When is the special meeting of stockholders scheduled to be held?
The special meeting of stockholders is scheduled to be held on July 30, 2024.
What is Cingulate Inc.'s primary business sector?
Cingulate Inc. operates in the Pharmaceutical Preparations sector, with the Standard Industrial Classification code 2834.
Where is Cingulate Inc. located?
Cingulate Inc. is located at 1901 W. 47th Place, Kansas City, KS 66205.
Was there a filing fee associated with this proxy statement supplement?
No fee was required for this filing, as indicated by the checkmark next to 'No fee required'.
Filing Stats: 334 words · 1 min read · ~1 pages · Grade level 14.6 · Accepted 2024-07-12 16:30:10
Key Financial Figures
- $10,000 — nce Advisors will receive approximately $10,000 for its assistance and will be reimburs
Filing Documents
- formdefa14a.htm (DEFA14A) — 20KB
- 0001493152-24-027107.txt ( ) — 21KB
From the Filing
Securities and Exchange Commission Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Materials Pursuant to Rule 14a-12 CINGULATE INC. (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 CINGULATE INC. 1901 W. 47 th Place Kansas PROXY SPECIAL MEETING OF STOCKHOLDERS To be held on July 30, 2024 The following information supplements and should be read in conjunction with the original Proxy Statement dated June 28, 2024 of Cingulate Inc. (“Cingulate” or the “Company”), which was mailed to stockholders on or about June 28, 2024 (the “Proxy SUPPLEMENTAL DISCLOSURE Cingulate is providing this supplement to reflect the following updates to the disclosure in the Proxy Statement. Proxy Solicitor The Company has retained Alliance Advisors to act as proxy solicitation agent. In connection with these services, Alliance Advisors will receive approximately $10,000 for its assistance and will be reimbursed for its reasonable out-of-pocket expenses. In addition, the Company has agreed to indemnify Alliance Advisors and certain related persons against certain liabilities relating to or arising out of Alliance Advisor’s engagement. Except as specifically supplemented by the information contained herein, all information set forth in the Proxy Statement remains unchanged. From and after the date of this supplement, all references to the “Proxy Statement” are to the Proxy Statement as supplemented hereby.